94.26
0.41 (0.44%)
Previous Close | 93.85 |
Open | 93.97 |
Volume | 589,094 |
Avg. Volume (3M) | 1,018,469 |
Market Cap | 8,121,096,192 |
Price / Earnings (TTM) | 57.13 |
Price / Earnings (Forward) | 20.20 |
Price / Sales | 6.26 |
Price / Book | 3.60 |
52 Weeks Range | |
Earnings Date | 2 Sep 2025 |
Profit Margin | 9.80% |
Operating Margin (TTM) | 25.50% |
Diluted EPS (TTM) | 1.37 |
Quarterly Revenue Growth (YOY) | 15.00% |
Quarterly Earnings Growth (YOY) | 87.10% |
Total Debt/Equity (MRQ) | 52.11% |
Current Ratio (MRQ) | 4.06 |
Operating Cash Flow (TTM) | 339.16 M |
Levered Free Cash Flow (TTM) | 96.00 M |
Return on Assets (TTM) | 4.57% |
Return on Equity (TTM) | 5.77% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Bullish | Mixed |
Health Information Services (Global) | Bullish | Mixed | |
Stock | HealthEquity, Inc. | Bearish | Mixed |
AIStockmoo Score
Analyst Consensus | 4.0 |
Insider Activity | -4.0 |
Price Volatility | 2.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 5.0 |
Average | 1.40 |
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Growth |
% Held by Insiders | 2.19% |
% Held by Institutions | 108.55% |
52 Weeks Range | ||
Price Target Range | ||
High | 134.00 (Jefferies, 42.16%) | Buy |
Median | 125.00 (32.61%) | |
Low | 110.00 (RBC Capital, 16.70%) | Buy |
Average | 123.00 (30.49%) | |
Total | 5 Buy | |
Avg. Price @ Call | 94.85 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Keybanc | 08 Oct 2025 | 120.00 (27.31%) | Buy | 92.09 |
Barrington Research | 03 Sep 2025 | 125.00 (32.61%) | Buy | 95.54 |
29 Aug 2025 | 125.00 (32.61%) | Buy | 89.33 | |
JP Morgan | 03 Sep 2025 | 126.00 (33.67%) | Buy | 95.54 |
Jefferies | 03 Sep 2025 | 134.00 (42.16%) | Buy | 95.54 |
RBC Capital | 03 Sep 2025 | 110.00 (16.70%) | Buy | 95.54 |
28 Aug 2025 | 109.00 (15.64%) | Buy | 88.29 |
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
FIORE MICHAEL HENRY | - | 88.14 | -3,430 | -302,368 |
LADD DELANO | - | 87.78 | -977 | -85,761 |
LUCANIA JAMES M | - | 87.78 | -2,393 | -210,058 |
NEELEMAN STEPHEN | - | 87.78 | -1,058 | -92,871 |
ROSNER ELIMELECH | - | 87.78 | -3,006 | -263,867 |
Aggregate Net Quantity | -10,864 | |||
Aggregate Net Value ($) | -954,924 | |||
Aggregate Avg. Buy ($) | - | |||
Aggregate Avg. Sell ($) | 87.90 |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
FIORE MICHAEL HENRY | Officer | 07 Oct 2025 | Automatic sell (-) | 1,781 | 88.50 | 157,619 |
ROSNER ELIMELECH | Officer | 06 Oct 2025 | Disposed (-) | 3,006 | 87.78 | 263,867 |
FIORE MICHAEL HENRY | Officer | 06 Oct 2025 | Disposed (-) | 1,649 | 87.78 | 144,749 |
NEELEMAN STEPHEN | Officer | 06 Oct 2025 | Disposed (-) | 1,058 | 87.78 | 92,871 |
LUCANIA JAMES M | Officer | 06 Oct 2025 | Disposed (-) | 2,393 | 87.78 | 210,058 |
LADD DELANO | Officer | 06 Oct 2025 | Disposed (-) | 977 | 87.78 | 85,761 |
Date | Type | Details |
---|---|---|
14 Oct 2025 | Announcement | HealthEquity Introduces GLP-1 Telehealth and Direct HSA Enrollment Platforms |
25 Sep 2025 | Announcement | HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation |
02 Sep 2025 | Announcement | HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results |
29 Aug 2025 | Announcement | HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education |
12 Aug 2025 | Announcement | HealthEquity Community Foundation Expands National Impact with $50,000 in Grants |
06 Aug 2025 | Announcement | HealthEquity Announces Dates to Report Second Quarter Earnings and Presentations at Investor Conferences |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |